CN101146782A - 间位取代的噻唑烷酮化合物、其制备方法以及作为药物的应用 - Google Patents

间位取代的噻唑烷酮化合物、其制备方法以及作为药物的应用 Download PDF

Info

Publication number
CN101146782A
CN101146782A CNA2005800483966A CN200580048396A CN101146782A CN 101146782 A CN101146782 A CN 101146782A CN A2005800483966 A CNA2005800483966 A CN A2005800483966A CN 200580048396 A CN200580048396 A CN 200580048396A CN 101146782 A CN101146782 A CN 101146782A
Authority
CN
China
Prior art keywords
group
many
differently
halogen
optional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800483966A
Other languages
English (en)
Chinese (zh)
Inventor
V·K·舒尔策
K·艾斯
L·沃特曼
D·科泽蒙德
O·普里恩
G·西迈斯特
H·赫斯-施通普
U·埃贝施佩歇尔
D·E·A·布里顿
I·伊斯拉姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CN101146782A publication Critical patent/CN101146782A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2005800483966A 2004-12-15 2005-12-12 间位取代的噻唑烷酮化合物、其制备方法以及作为药物的应用 Pending CN101146782A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004061503.9 2004-12-15
DE102004061503A DE102004061503A1 (de) 2004-12-15 2004-12-15 Metasubstituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
US60/637,777 2004-12-22

Publications (1)

Publication Number Publication Date
CN101146782A true CN101146782A (zh) 2008-03-19

Family

ID=36580263

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800483966A Pending CN101146782A (zh) 2004-12-15 2005-12-12 间位取代的噻唑烷酮化合物、其制备方法以及作为药物的应用

Country Status (3)

Country Link
CN (1) CN101146782A (de)
DE (1) DE102004061503A1 (de)
ZA (1) ZA200705782B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402830A (zh) * 2014-11-27 2015-03-11 太仓运通生物化工有限公司 一种2-氯嘧啶的合成方法
CN114907288A (zh) * 2022-05-13 2022-08-16 中国医学科学院医药生物技术研究所 硝基苯类化合物在制备铜绿假单胞菌群体感应抑制剂中的应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2065039A1 (de) 2007-11-27 2009-06-03 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Selektivinhibitoren von poloartiger Kinase 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222845A1 (en) * 2002-05-03 2003-11-17 Schering Aktiengesellschaft Thiazolidinones and the use thereof as polo-like kinase inhibitors
DE10351744A1 (de) * 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104402830A (zh) * 2014-11-27 2015-03-11 太仓运通生物化工有限公司 一种2-氯嘧啶的合成方法
CN114907288A (zh) * 2022-05-13 2022-08-16 中国医学科学院医药生物技术研究所 硝基苯类化合物在制备铜绿假单胞菌群体感应抑制剂中的应用
CN114907288B (zh) * 2022-05-13 2023-12-08 中国医学科学院医药生物技术研究所 硝基苯类化合物在制备铜绿假单胞菌群体感应抑制剂中的应用

Also Published As

Publication number Publication date
DE102004061503A1 (de) 2006-06-29
ZA200705782B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
CN1656073B (zh) 可用于治疗蛋白激酶依赖性疾病的二芳基脲衍生物
ES2237430T3 (es) Nuevos derivados carboxamida heterociclicos.
US7612200B2 (en) Inhibitors of protein kinases
ES2222363T3 (es) Medicamento contra enfermedades viricas.
ES2502941T3 (es) Método de preparación de compuestos de amida de dihidroindeno, las composiciones farmacéuticas que contienen dichos compuestos y el uso como inhibidor de proteína quinasas
PT1415987E (pt) Compostos contendo aneis aromáticos azotados utilizados como agentes anti-cancerígenos.
CN104030990A (zh) 苯基氨基嘧啶化合物及其用途
CN102369202A (zh) 氮杂喹啉酮衍生物及其应用
ZA200409796B (de)
CN101155791A (zh) 作为极体样激酶（plk）抑制剂药剂的噻唑烷酮
JP2008524139A (ja) メタ置換チアゾリノン類、それらの製造及び医薬としての使用
EP3303325A1 (de) Cannabinoid-rezeptorvermittelnde verbindungen
JPH02270821A (ja) チアゾリジニルアルキレンピペラジン誘導体含有医薬組成物
ES2417488T3 (es) Compuestos de triazol adecuados para tratar trastornos que responden a la modulación del receptor de dopamina D3
CN102724975A (zh) IRE-1α抑制剂
CN101146782A (zh) 间位取代的噻唑烷酮化合物、其制备方法以及作为药物的应用
JP2007509892A (ja) チアゾリジノン類、それらの生成及び医薬剤としての使用
EP0104614B1 (de) Phenylpiperazin-Derivate und Verfahren zu deren Herstellung
CN101888989A (zh) 新型芳基钾通道阻断剂及其应用
KR900000366B1 (ko) 2-(4-부틸피페라진-1-일)피리딘의 항 정신질환성 환상 이미드 유도체 및 그의 제조방법
JP2007517886A (ja) 新規な化学化合物
IE921214A1 (en) Pyrimidine derivatives for enhancing antitumor activity
BRPI0609948A2 (pt) tiazolidinonas sem nitrogênio básico, sua produção e uso como agentes farmacêuticos
PT92605B (pt) Processo de preparacao de derivados da 2-imino-6-polifluoroalcoxibenzotiazolina
CN110066273A (zh) 一种含三氮唑环的单芳基嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1114097

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080319

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1114097

Country of ref document: HK